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MOLECULAR AND SYNAPTIC MECHANISMS
The general anaesthetic etomidate inhibits the excitability
of mouse thalamocortical relay neurons by modulating
multiple modes of GABAA receptor-mediated inhibition
Murray B. Herd, Jeremy J. Lambert and Delia Belelli
Division of Neuroscience, Medical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee
DD1 9SY, UK
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Abstract
Modulation of thalamocortical (TC) relay neuron function has been implicated in the sedative and hypnotic effects of general ana-
esthetics. Inhibition of TC neurons is mediated predominantly by a combination of phasic and tonic inhibition, together with a
recently described ‘spillover’ mode of inhibition, generated by the dynamic recruitment of extrasynaptic c-aminobutyric acid
(GABA)A receptors (GABAARs). Previous studies demonstrated that the intravenous anaesthetic etomidate enhances tonic and
phasic inhibition in TC relay neurons, but it is not known how etomidate may influence spillover inhibition. Moreover, it is unclear
how etomidate influences the excitability of TC neurons. Thus, to investigate the relative contribution of synaptic (a1b2c2) and ex-
trasynaptic (a4b2d) GABAARs to the thalamic effects of etomidate, we performed whole-cell recordings from mouse TC neurons
lacking synaptic (a10/0) or extrasynaptic (d0/0) GABAARs. Etomidate (3 lM) significantly inhibited action-potential discharge in a
manner that was dependent on facilitation of both synaptic and extrasynaptic GABAARs, although enhanced tonic inhibition was
dominant in this respect. Additionally, phasic inhibition evoked by stimulation of the nucleus reticularis exhibited a spillover com-
ponent mediated by d-GABAARs, which was significantly prolonged in the presence of etomidate. Thus, etomidate greatly
enhanced the transient suppression of TC spike trains by evoked inhibitory postsynaptic potentials. Collectively, these results sug-
gest that the deactivation of thalamus observed during etomidate-induced anaesthesia involves potentiation of tonic and phasic
inhibition, and implicate amplification of spillover inhibition as a novel mechanism to regulate the gating of sensory information
through the thalamus during anaesthetic states.
Introduction
The ability of general anaesthetics to impair consciousness, and
induce analgesia, amnesia and immobility, has been exploited clini-
cally for over a century (Rudolph & Antkowiak, 2004). Yet, despite
their routine clinical use, the neuroanatomical substrates of anaes-
thetic actions remain enigmatic, with several components of the cir-
cuitry regulating the sleep–wake cycle implicated to date (Franks,
2008). Nevertheless, electrophysiological, neuroimaging and model-
ling studies consistently pinpoint the thalamus as an important neu-
ral locus for anaesthetic-induced hypnosis (Angel, 1991; Fiset et al.,
1999; Alkire et al., 2000; White & Alkire, 2003; Ching et al.,
2010; Andrada et al., 2012). Such observations are consistent with
the classical role of the thalamus in controlling transitions between
conscious states (Steriade et al., 1993).
At the cellular level, c-aminobutyric acid (GABA)A receptors
(GABAARs) represent key molecular targets for several general
anaesthetics, including the intravenous agents etomidate and propo-
fol (Hales & Lambert, 1991; Orser et al., 1994; Uchida et al.,
1995). Importantly, anaesthetic-induced modulation of inhibition
may be influenced by the molecular identity of GABAARs (Belelli
et al., 1996; Bonin & Orser, 2008), which are composed of five su-
bunits drawn from a pool of 19 isoforms (Olsen & Sieghart, 2009).
Etomidate is unique in this respect, displaying selectivity for b2- or
b3-containing receptors vs. those incorporating the b1 subunit (Hill-
Venning et al., 1997). Subunit composition additionally influences
the functional properties and spatiotemporal expression of
GABAARs. Thus, synaptic GABAARs, which mediate brief phasic
inhibition, are composed of axbxc2 subunits, whereas receptors
incorporating a d rather than a c2 subunit, are localized to extra- or
peri-synaptic locations, and mediate persistent tonic inhibition (Far-
rant & Nusser, 2005). However, a substantial number of GABAARs
with a typically ‘synaptic’ subunit composition also exist extrasy-
naptically, although the functional role of such receptors remains to
be established (Kasugai et al., 2010). d-GABAARs have been pro-
posed as important general anaesthetic targets, a suggestion sup-
ported by their abundant expression in brain regions implicated in
some anaesthetic behaviours, including thalamocortical (TC) relay
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nuclei (Belelli et al., 2005; Jia et al., 2005). However, while etomi-
date enhances both phasic and tonic currents recorded from TC neu-
rons (Belelli et al., 2005), it is unknown how these respective
actions influence the excitability of relay neurons.
Recently, we demonstrated that in addition to generating tonic inhi-
bition, d-GABAARs of TC neurons may be recruited via a spillover-
like mechanism to prolong phasic inhibition generated in response to
presynaptic spike bursts (Herd et al., 2013). This observation may
have particular relevance to anaesthetic effects in thalamus, given that
nucleus reticularis thalami (nRT) neurons, which provide the major
source of GABA-ergic innervation to TC neurons, exhibit prominent
spike bursts during unconscious states. Whether and how anaesthetics
may influence this ‘burst-mediated spillover’ mode is not known.
Here, we investigated the relative contribution of synaptic and
extrasynaptic GABAARs to the inhibitory effects of etomidate on
relay neuron output. Using transgenic mice in which TC relay neu-
rons lack synaptic (a10/0, Peden et al., 2008) or extrasynaptic (d0/0,
Herd et al., 2009) GABAARs, we report that, although enhancement
of tonic inhibition dominates the inhibitory effect of etomidate on
TC neuron excitability, the synaptic a1bc2 GABAAR population
also significantly influences the effects of the anaesthetic. Moreover,
we demonstrate that etomidate greatly prolongs burst-mediated spill-
over inhibition, providing a novel mechanism whereby a putatively
relevant network may be influenced by anaesthetics.
Materials and methods
Use of a10/0 and d0/0 mice as models to investigate the
thalamic effects of etomidate
Compensatory adaptations represent a significant caveat to the inter-
pretation of experiments utilizing constitutive knockout mice.
Indeed, biochemical and immunohistochemical evidence revealed
compensatory up-regulation of a2 and/or a3 subunits in the neocor-
tex and cerebellum of a10/0 mice (Sur et al., 2001; Kralic et al.,
2002a,b). However, in the thalamus of a10/0 mice, the ablated a1
subunits are not replaced by a2 or a3 subunits (Kralic et al., 2006)
and a3 expression remains unaltered in the presynaptic nRT (Kralic
et al., 2006). Thus, at the functional level, the lack of any clear
upregulation of the remaining palette of GABAAR subunits is
reflected by a complete lack of miniature inhibitory postsynaptic
currents (mIPSCs) in mature ventrobasal (VB) neurons, but unal-
tered mIPSC properties in the nRT (Peden et al., 2008). Moreover,
extrasynaptic GABAARs do not appear to compensate for the lost pha-
sic inhibition, as tonic inhibition is not significantly altered in a10/0
VB neurons, at least at the limited age range studied here (Herd et al.,
2009). In the d0/0 mouse (Mihalek et al., 1999), increased expression
of c2 subunits has been reported (Tretter et al., 2001; Peng et al.,
2002). Importantly, however, receptors incorporating a1, a2, a3 or a5
subunits do not appear to substitute for the lost d-containing receptors
(Peng et al., 2002). In agreement, we did not observe any clear altera-
tions in the properties of relay neuron mIPSCs that could compensate
for the greatly reduced tonic inhibition in d0/0 mice (Herd et al.,
2009). Thus, the lack of clear adaptive changes in the properties of
phasic and tonic inhibition at the thalamic level in the a10/0 and d0/0
mice validates their utility as models to investigate the influence of
etomidate on relay neuron excitability.
The a10/0 and d0/0 mice were generated on a mixed C57BL6/
J-129SvEv (a10/0) or single C57BL6 (d0/0) background at the Merck
Research Laboratories at the Neuroscience Research Centre in Harlow
and at the University of Pittsburgh, respectively, as described
previously (Mihalek et al., 1999; Sur et al., 2001). Brain slices were
prepared from the first two generations of a10/0 and d0/0 and their
respective wild-type (WT) mice from breeding pairs derived from the
corresponding heterozygous mice bred at the University of Dundee.
Measures of inhibition (phasic and tonic) and neuronal excitability
[input resistance (IR) and action potential rheobase] did not differ
between a1+/+ and d+/+ (data not shown). Results obtained from the
respective WT strains were thus pooled.
Slice preparation
Animals were killed by cervical dislocation in accordance with
Schedule 1 of the UK Government Animals (Scientific Procedures)
Act 1986. Thalamic slices were prepared from mice of either sex
(postnatal days 16–24) according to standard protocols (Herd et al.,
2009). Dissected brains were sliced horizontally (300–350 lm) in
an ice-cold sucrose-based cutting solution, using a Leica VT1000S
vibratome (Nussloch, Germany). The slices were incubated at room
temperature (20–23 °C) for a minimum of 1 h prior to recording in
an oxygenated, extracellular solution (ECS) containing (in mM):
126 NaCl, 2.95 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 10 D-
glucose and 2 MgCl2 (pH 7.4; 300–310 mOsm).
Electrophysiology
Electrophysiological recordings were performed from thalamic slices
maintained in warmed ECS (30 °C), using an Axopatch 200B ampli-
fier (Molecular Devices, Sunnyvale, CA, USA). Thalamocortical
relay neurons of the VB complex were visually identified with an
Olympus BX51 microscope (Olympus, Southall, UK), equipped with
differential interference contrast/infrared optics and a charge-coupled
device camera. Whole-cell voltage- and current-clamp recordings
from VB neurons were obtained using patch pipettes prepared from
thick-walled borosilicate glass (King Precision Glass, Claremont,
CA, USA) using a Narishige PC-10 vertical puller, and had open tip
resistances of 4–6 MΩ when filled with a solution containing [in
mM): 130 K-gluconate, 2 KCl, 2 NaCl, 10 HEPES (4-(2-hydroxyeth-
yl)-1-piperazineethanesulfonic acid), 0.2 EGTA (ethylenediaminetet-
raacetic acid), 2 Mg adenosine triphosphate, 0.5 Na guanosine-
50-triphosphate, 10 Tris-phosphocreatine, adjusted to pH 7.2–7.3 with
KOH, 280–290 mOsm. Series resistance was intermittently moni-
tored, compensated for (up to 80% for voltage-clamp, 100% for cur-
rent-clamp) and recordings discarded if values changed by more than
25%, or increased beyond 25 MΩ. Voltage-clamp recordings were
performed at a holding potential of 50 mV (GABA Erev ~
85 mV), and thus responses mediated by GABAARs were out-
wardly directed. Inhibitory responses were evoked in VB neurons
using a bipolar tungsten electrode (World Precision Instruments,
Stevenage, UK), placed within the borders of the nRT. Stimuli were
delivered (20-ls duration, 0.1 Hz) using a Digitimer DS3 Isolated
Stimulator (Digitimer, Welwyn Garden City, UK), with stimulus
intensity adjusted to the minimum value that avoided failures, but
still generated IPSC bursts of relatively consistent amplitude [i.e. for
each recording, the excitatory IPSC (eIPSC) peak amplitude standard
deviation (SD) was <15% of the mean peak amplitude obtained from
that cell; WT = 8.5  1.4%, n = 7; a10/0 = 10.5  1.4%, n = 7;
d0/0 = 8.9  0.8%]. At the stimulation intensities utilized, the num-
ber of peaks observed in response to each stimulus was relatively
consistent from trial to trial (SD = 0.94 and 1.30 for WT and d0/0,
respectively). Although we find GABABR activation is minimal
under these recording conditions/stimulation parameters (data not
shown), we performed the experiments in the presence of CGP
55845 (1 lM) to block GABABRs. Holding currents (Ihold) were
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continuously monitored throughout voltage-clamp recordings to deter-
mine the effect of etomidate on tonic inhibition. Current-clamp record-
ings were also performed to determine the effect of burst-mediated
inhibition on VB neuron spiking. Thus, evoked inhibitory postsynap-
tic potentials (eIPSPs) were evoked at regular intervals (0.09–
0.11 Hz) during tonic trains of action potentials. Tonic spike trains
were generated by depolarizing the recorded neuron to a supra-thresh-
old membrane potential (Vm) using depolarizing direct current (DC)
injection delivered via the recording electrode. The amplitude of
injected DC was carefully adjusted to maintain a tonic spike frequency
of ~4–8 Hz. In this paradigm, eIPSPs generated a transient cessation
of action potential discharge. eIPSPs were also recorded at or near the
resting potential, and in some cells a rebound low-threshold Ca2+
potential was observed, which was commonly crowned by a high-fre-
quency spike burst. In such recordings, the latency to rebound, relative
to eIPSP onset, was determined for each event before and after etomi-
date application. VB neuron excitability was also examined in current-
clamp experiments by monitoring action potential output in response
to a family of current steps. The stimulation protocol consisted of a set
of hyperpolarizing and depolarizing current pulses (200 to +300 pA,
400-ms duration, in increments of 50 pA, every 15 s), delivered via
the recording electrode before and after the bath application of etomi-
date. Current stimulations were delivered from a holding potential of
~66 mV to isolate the tonic spike mode during depolarizing
stimulations. The number of action potentials generated in response to
positive current steps, and within low-threshold Ca2+ current
(IT)-mediated rebound bursts following release from hyperpolariza-
tion, were counted for each condition. Membrane IR was calculated
according to Ohms’s law following delivery of small (20 pA,
300 ms) hyperpolarizing current steps from the resting membrane
potential. A measured liquid junction potential of 11 mV was cor-
rected offline. Recordings were filtered at 2 or 5 kHz for voltage- and
current-clamp recordings, respectively, and acquired directly to PC
using a NI-DAQmx analog-to-digital interface (National Instruments
UK, Newbury, UK) for subsequent offline analysis.
Data analysis
All electrophysiological data were analysed offline using the Strath-
clyde Electrophysiology Software, WinEDR/WinWCP (J. Dempster,
University of Strathclyde, UK) software package. For voltage-clamp
experiments, eIPSCs were analysed with respect to peak amplitude,
10–90% rise times and charge transfer. The decay time course
following the final peak of multi-peak eIPSCs was adequately
described by fitting a double exponential function (y(t) =
A1e
(t/s1) + A2e
(t/s2)) using the least squares method, where A is
amplitude, t is time and s is the decay time constant. Analysis of
the SD of residuals and use of the F-test was used to compare good-
ness of fit, confirming an improved fit of the decay was achieved
when employing a double- rather than a mono-exponential function.
Thus, a weighted decay time constant (sw) was also calculated
according to the equation, sw = s1P1 + s2P2, where s1 and s2 are
the decay time constants of the first and second exponential func-
tions and P1 and P2 are the proportions of the synaptic current
decay described by each component. To determine the effect of
etomidate on VB tonic inhibition, etomidate-induced outward shifts
of the holding current (Ihold) were quantified by sampling sequential
51.2-ms epochs for a 2-min period before, and after application of
etomidate (Belelli et al., 2005). Epochs containing evoked or
spontaneous synaptic currents were excluded. The mean holding
current in each condition was determined from Gaussian fits to the
distribution of holding current values sampled from each epoch.
For current-clamp experiments investigating the effect of etomidate
on VB neuron excitability, input–output curves were constructed by
plotting the number of action potentials generated as a function of
stimulus amplitude. To quantify etomidate-induced shifts in input–
output curves, data were fit with a Boltzman sigmoidal curve accord-
ing to the equation y(x) = Nmax/1 + e
(X – X
50
)/S + Nmax), where Nmax is
the number of action potentials generated at the maximum stimulus
amplitude (in this case 300 pA), X is the stimulus amplitude, X50 is
the stimulus amplitude producing half-maximal spike output (hereafter
‘EA50’) and S is the slope factor. For experiments investigating the
effect of eIPSPs on tonic spike trains, inter-spike intervals (ISIs) were
measured throughout the spike train. For baseline measurements, ISIs
were determined for a 5-s period preceding each eIPSP (minimum of
three stimulations) to ensure spike rates recovered to stable frequen-
cies following inhibition. The ISI during an IPSP was simply the inter-
val between the final spike prior to delivery of an eIPSP and the first
spike following recovery from inhibition. The transient suppression of
tonic spike activity induced by an eIPSP was observed as an immedi-
ate and obvious increase in the ISI (see Figs 2 and 3).
All results are reported as the arithmetic mean  standard error of
the mean (SEM). Statistical significance of the mean data was
assessed with a Student’s t test (paired, or unpaired), one-way analy-
sis of variance (ANOVA) or a two-way mixed-design ANOVA as appro-
priate, using the SPSS (SPSS Inc., Chicago, IL USA) software
package. Sphericity was assessed with Mauchly’s test, and degrees
of freedom were adjusted using a Greenhouse–Geisser correction if
sphericity was violated. Post-hoc multiple comparisons were con-
ducted using Tukey’s test. Unless explicitly stated, statistical signifi-
cance was assessed using Student’s t-test. Boltzmann curve fits were
performed in Origin v7 (OriginLab, Northampton, MA, USA).
Salts and drugs
R-(+)-etomidate (supplied by Merck, Glasgow, UK) was prepared as
a concentrated aqueous stock and diluted 1000-fold in ECS to a
final concentration of 3 lM. CGP 55835 (Abcam, Cambridge, UK)
was prepared in dimethyl sulphoxide (DMSO) as a 1000-fold con-
centrated stock solution and diluted in ECS to the final desired con-
centration. The final DMSO concentration (0.1%) had no effect on
any of the measured parameters (data not shown). Etomidate was
applied via the perfusion system (2–4 mL/min) and allowed to infil-
trate the slice for a minimum of 10 min. All other salts and drugs
were obtained either from Sigma-Aldrich (Poole, UK), Tocris Bio-
science (Bristol, UK) or VWR (Lutterworth, UK).
Results
Etomidate prolongs eIPSCs by potentiating synaptic and
extrasynaptic GABAARs
In VB neurons, etomidate prolongs mIPSCs and enhances tonic cur-
rents mediated by a1b2c2- and by a4b2d GABAARs, respectively
(Belelli et al., 2005). However, our recent demonstration that thalamic
d-GABAARs may influence the kinetics of action potential-dependent
phasic inhibition, particularly in response to spike bursts (Herd et al.,
2013), provides an additional route whereby etomidate may influence
VB inhibition. Thus, we investigated the effects of etomidate on elec-
trically evoked IPSCs generated in response to extracellular stimula-
tion of the nRT of WT, a10/0 and d0/0 mouse brain slices.
In voltage-clamp recordings utilising K+-gluconate-based pipette
solutions (GABAAR Erev ~ 85 mV, Vh = 50 mV), extracellular
stimulation of the nRT in WT brain slices generated outwardly
© 2014 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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directed eIPSCs composed of multiple peaks, and a bi-exponential
decay phase following the final peak (Table 1, Fig. 1A). The multi-
peak nature of the eIPSCs is consistent with the generation of
IT-dependent spike bursts in presynaptic neurons. Application of
etomidate (3 lM) greatly increased the eIPSC peak amplitude
(Table 2, Fig. 1A and D, n = 7, P < 0.001), and sw (Table 2,
Fig. 1A and E, P < 0.001), resulting in a significant enhancement
of eIPSC charge transfer (Table 2, Fig. 1A and F, P = 0.001). Con-
sistent with our previous report (Herd et al., 2013), robust residual
eIPSCs were recorded from a10/0 VB neurons, despite the absence of
synaptic GABAARs (Table 1, Fig. 1B). The slow kinetics of the ris-
ing and decaying phase of a10/0 eIPSCs, together with their sensitivity
to modulation by the d-selective compound DS2 (Wafford et al.,
2009; Herd et al., 2013; Jensen et al., 2013), indicate that such resid-
ual events are mediated by recruitment of d-containing extrasynaptic
(e)GABAARs in response to nRT spike bursts. Importantly, acute
application of etomidate greatly enhanced the peak amplitude
(Table 2, Fig. 1B and D, n = 7, P < 0.001) and sw (Table 2, Fig. 1B
and E, P < 0.001) of a10/0 eIPSCs, leading to a significant increase in
their charge transfer (Table 2, Fig. 1F, P < 0.001). However, the
overall effect of etomidate on eIPSC charge transfer was reduced for
a10/0 relative to WT neurons (Fig. 1F, drug 9 genotype interaction,
F2,19 = 7.21, P = 0.005, mixed ANOVA), suggesting that a significant
proportion of the effects of etomidate on WT eIPSCs are mediated by
synaptic GABAARs. In support, etomidate also enhanced eIPSCs
recorded from d0/0 neurons (Fig. 1C). In agreement with previous
findings (Herd et al., 2013), eIPSCs recorded from d0/0 VB neurons
exhibited faster decay kinetics, due to the abolished eGABAAR com-
ponent normally engaged by neurally released GABA acting on WT
neurons (Table 1). Nevertheless, despite the absence of the
eGABAAR contribution to eIPSC properties, etomidate (3 lM) signifi-
cantly increased eIPSC peak amplitude (Table 2, Fig. 1C and D,
n = 8, P = 0.003), sw (Table 2, Fig. 1C and E, P < 0.001) and
charge transfer (Table 2, Fig. 1F, P = 0.003). However, as observed
for a10/0 recordings, deletion of the d subunit significantly reduced the
overall effect of etomidate on eIPSC charge transfer relative to WT
(Fig. 1F, drug 9 genotype interaction, F2,19 = 7.21, P = 0.005,
mixed ANOVA).
Etomidate prolongs phasic suppression of VB tonic firing and
delays post-inhibitory rebound burst firing
During conscious brain states, thalamocortical relay neurons exist in
a relatively depolarized state, and respond to incoming excitatory
inputs in the tonic ‘relay’ mode (Steriade et al., 1993). Given the
shared roles of synaptic and extrasynaptic GABAARs in regulating
the kinetics of inhibitory synaptic transmission (see above), we
hypothesized that these receptor populations should combine to reg-
ulate the effect of etomidate on phasic inhibition of tonic VB spike
output.
To explore these questions we performed whole-cell current-
clamp recordings of tonic firing from WT, a10/0 and d0/0 slices. VB
neurons were slowly depolarized from the resting membrane poten-
tial (Table 3) by DC injection until they discharged trains of tonic
spikes, occurring at ~4–8 Hz (mean spike frequency: WT = 5.8 
0.3 Hz, n = 13; a10/0 = 5.7  0.3 Hz, n = 12; d0/0 = 5.5  0.1 Hz,
n = 8; F2,32 = 0.35, P = 0.71, one-way ANOVA). We then evoked
IPSPs by extracellular stimulation of the nRT (0.09–0.11 Hz stimulation
frequency) at regular intervals during the tonic train, and quantified
the duration of the eIPSP-induced suppression of tonic firing across
strains (i.e. ISI), before and after etomidate (3 lM) (Figs 2 and 3). As
illustrated in the representative example in Fig. 2A, stimulation of the
nRT in WT brain slices evoked reproducible IPSPs, which transiently
suppressed tonic spiking of VB neurons (baseline ISI = 173  8 ms;
ISI during IPSP = 1106  118 ms; n = 13, P < 0.001; Fig. 2D).
Remarkably, despite the absence of a detectable synaptic receptor pop-
ulation in VB, equivalent stimulation of the nRT in a10/0 slices gener-
ated eIPSPs that transiently inhibited tonic spiking, albeit to a lesser
extent than in WT tissue (baseline ISI = 176  10 ms; ISI during
IPSP = 672  67 ms; n = 12, P < 0.001; stimulation 9 genotype
interaction, F2,28 = 7.04, P = 0.003, mixed ANOVA; Fig. 2B and D).
Similarly, in d0/0 slices, eIPSPs induced a reproducible blockade of
VB tonic firing, although the duration of spike suppression was signif-
icantly (and similar to a10/0) reduced relative to WT recordings (base-
line ISI = 180  5 ms; ISI during IPSP = 650  49 ms; n = 8,
P < 0.001, stimulation 9 genotype interaction, F2,28 = 7.04, P =
0.003, mixed ANOVA; Fig. 2C and D), consistent with voltage-clamp
experiments demonstrating faster eIPSC decay time in the absence of
d-GABAARs.
Consistent with the robust potentiation of eIPSCs observed in volt-
age-clamp experiments, etomidate (3 lM) significantly prolonged the
duration of tonic firing suppression induced by eIPSPs in WT (ISI dur-
ing IPSP: control = 1000  148 ms; + etomidate = 1624  161 ms;
n = 8, P < 0.001; Fig. 3A and D), a10/0 (ISI during IPSP: control =
737  67 ms; + etomidate = 1383  78 ms; n = 9, P < 0.001;
Fig. 3B and D) and d0/0 brain slices (ISI during IPSP: control =
670  54 ms; + etomidate = 1427  206 ms; n = 6, P < 0.001;
Fig. 3C and D). Surprisingly, however, the effect of etomidate on
eIPSP-induced suppression of tonic firing (i.e. the difference in ISI
during an IPSP before and after etomidate application) was not signifi-
cantly different between strains (Fig. 3D, F2,20 = 0.56, P = 0.58,
mixed ANOVA), despite the ablation of either major subcellular popula-
tion of GABAAR.
In a subset of these recordings, eIPSPs recorded at or slightly
depolarized to the resting membrane potential were of sufficient
amplitude to generate a rebound low-threshold Ca2+ potential and
associated spike burst at the offset of the eIPSP (von Krosigk et al.,
1993). We therefore investigated the effect of etomidate on the post-
inhibitory rebound properties by measuring the latency to rebound.
Consistent with the prolongation of evoked phasic inhibition, etomi-
date significantly delayed the timing of rebound bursts in WT record-
ings (Fig. 4A and C, n = 4, P = 0.009) at similar Vm (pre-eIPSP
Vm = 68.3  1.2 and 69.0  1.2 mV for control and etomidate,
respectively). Similarly, in d0/0 recordings, the latency to post-inhibi-
tory rebound was significantly increased in the presence of etomidate
(Fig. 4B and C, n = 5, P < 0.001) at equivalent Vm (pre-eIPSP
Table 1. Comparison of eIPSC properties recorded from WT, a10/0 and d0/0
mice
WT (n = 16) a10/0 (n = 14) d0/0 (n = 10)
No. of peaks/eIPSC 7.6  0.4 N/D 7.2  0.4
Mean frequency of
peaks/eIPSC (Hz)
269.8  16.2 N/D 270.9  14.0
Peak amplitude (pA) 604.1  70.7 142.9  22.7*** 493.2  58.6
Rise Time to 1st
peak (ms)
1.1  0.2 14.6  0.9*** 1.1  0.1
Charge transfer (pC) 39.0  5.5 11.5  2.1*** 16.1  2.3**
T50 (ms) 28.2  1.7 46.2  6.0** 17.6  1.0***
s1 (ms) 28.2  2.5 44.9  5.8** 9.9  0.7**
s2 (ms) 219.0  18.8 233.9  19.8 50.8  3.5***
% s1 82.0  3.6 84.8  2.9 72.5  2.3
sw (ms) 58.3  6.3 76.3  11.3 21.5  2.1*
*P < 0.05, **P < 0.01, ***P < 0.001 vs. WT, one-way ANOVA, Tukey’s
post-hoc test. N/D, not determined.
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Table 2. Comparison of the effect of etomidate on eIPSCs recorded from WT, a10/0 and d0/0 mice
WT (n = 7) a10/0 (n = 7) d0/0 (n = 8)
Control 3 lM etomidate Control 3 lM etomidate Control 3 lM etomidate
Peak amplitude (pA) 599  101 1037  152*** 198  31 465  40*** 477  73 740  121**
sw (ms) 53  7 144  9*** 73  14 139  20*** 21  3 93  9***
Charge transfer (pC) 40  8 184  32** 17  3 76  8*** 16  3 81  17**
**P < 0.01, ***P < 0.001, paired t-test.
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Fig. 1. Etomidate prolongs the duration of evoked phasic inhibition in VB neurons by potentiating synaptic and extrasynaptic GABAA receptors. (A–C) Super-
imposed, representative, evoked IPSCs recorded from WT (A), a10/0 (B) and d0/0 (C) VB neurons under control conditions (black) and in the presence of 3 lM
etomidate (grey). Currents were evoked by extracellular stimulation of the nRT (single shocks, 20 ls duration). (D–E) Bar graphs illustrating the effect of
etomidate on eIPSC peak amplitude (D), sw (E) and charge transfer (F) in WT (black bars, n = 7), a1
0/0 (dark grey bars, n = 7) and d0/0 (light grey bars,
n = 8) thalamic slices. **P < 0.01, ***P < 0.001 vs. control, paired t-test. †P < 0.05, ††P < 0.01 vs. WT, mixed ANOVA, Tukey’s post-hoc test. Etom, etomi-
date.
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Vm = 67.8  0.3 and 68.3  0.2 mV for control and etomidate,
respectively). eIPSPs recorded from a10/0 slices did not elicit rebound
bursts, although in all seven recordings, the duration of eIPSPs
recorded from equivalent membrane potentials were prolonged (data
not shown). These observations imply that both synaptic and extrasy-
naptic receptor modulation can influence post-inhibitory rebound tim-
ing.
Deletion of the a1 or d subunit influences the etomidate-
induced enhancement of the VB tonic current
While quantifying the effects of etomidate on eIPSCs, we simulta-
neously monitored the VB holding current in each mouse strain to
further understand the contribution of a1bc2 and a4bd GABAARs
Table 3. Comparison of resting membrane potential (Vm) and input resis-
tance recorded from WT, a10/0 and d0/0 mice
WT (n = 38) a10/0 (n = 19) d0/0 (n = 27)
Vm (mV) –72.5  0.5 –72.0  0.9 –73.5  0.5
Input resistance (MΩ) 288  13 274  22 328  20
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Fig. 2. Synaptic and extrasynaptic GABAARs influence phasic suppression of VB tonic firing. (A–C) Representative current-clamp recordings illustrating the
suppression of tonic action potential discharge induced by evoked IPSPs in WT (A), a10/0 (B) and d0/0 (C) thalamic slices. The plots to the right of each trace
depict the inter-spike interval (ISI) over the course of the illustrated recordings, and demonstrate the increase in ISI (i.e. spike suppression) during delivery of
the eIPSP. Evoked IPSPs were generated by extracellular stimulation of the nRT. (D) Bar graph comparing the effect of eIPSPs on ISI during tonic spike trains
recorded from WT (n = 13), a10/0 (n = 12) and d0/0 (n = 8) VB neurons. ***P < 0.001 vs. baseline ISI, paired t-test. †P < 0.05 vs. WT, mixed ANOVA,
Tukey’s post hoc test.
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Fig. 3. Etomidate prolongs phasic suppression of VB tonic firing by potentiating synaptic and extrasynaptic GABAARs. (A–C) Whole-cell current-clamp
recordings illustrating the suppression of VB tonic firing under control conditions (Ai–Ci), and in the presence of 3 lM etomidate (Aii–Cii), in WT (A), a10/0
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genotype (P = 0.58, mixed ANOVA).
© 2014 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
European Journal of Neuroscience, 40, 2487–2501
Etomidate inhibition of thalamocortical neurons 2493
to the effects of the anaesthetic on VB tonic inhibition. Bath
application of 3 lM etomidate induced a clear outward shift in VB
holding current (37.2  5.0 pA, n = 8; Fig. 5A and G), with a time
course similar to that observed for potentiation of eIPSCs (Fig. 5B,
panels i and ii). In previous work, we found that deletion of a1-con-
taining receptors did not significantly influence baseline tonic
current amplitudes, consistent with the hypothesis that VB tonic
inhibition is mediated predominantly by a4b2d receptors (Chandra
et al., 2006; Herd et al., 2009). Thus, it was surprising that while
etomidate application induced a clear outward current in a10/0 VB
recordings (20.7  2.9 pA, n = 9) concurrently with potentiation of
residual eIPSCs (Fig. 5C and D), the magnitude of the outward cur-
rent shift was significantly reduced relative to WT (Fig. 5G,
drug 9 genotype interaction, F2,21 = 20.11, P < 0.001, mixed ANO-
VA). In recordings from VB neurons of d0/0 mice, bath application
of 3 lM etomidate induced only a minimal outward current
(5.0  1.0 pA, n = 7; P < 0.001 vs. WT; P = 0.012 vs. a10/0,
mixed ANOVA, Tukey’s post-hoc test; Fig. 5E and G), while robustly
potentiating eIPSCs (Fig. 5F).
Deletion of a1 or d subunits attenuates the effect of etomidate
on VB neuron excitability
Given that etomidate modulation of VB tonic inhibition is signifi-
cantly reduced in a10/0 and d0/0 neurons, such genetic manipulations
are thus predicted to influence the effect of the anaesthetic on cellu-
lar excitability. To investigate this hypothesis, we examined the
effect of etomidate on VB input–output (I–O) relationships gener-
ated in response to a family of current steps (200 to +300 pA,
400 ms duration, 50-pA increments every 15 s). Current steps were
delivered while neurons were held at a membrane potential of
~66 mV; at such potentials, IT is largely inactivated (Coulter
et al., 1989). First, we compared I-O relationships across WT, a10/0
and d0/0 under control conditions to determine if basic electrical
excitability was affected by the mutations (Fig. 6). Across all three
strains, in accordance with classical TC neuron physiology, hyperpo-
larizing currents steps of sufficient amplitude generated a sagging,
hyperpolarization-activated cation current (IH)-dependent membrane
potential response, followed by a rebound low-threshold Ca2+ poten-
tial, crowned by a high-frequency spike burst (spikes per burst,
WT = 2–10, n = 23; a10/0 = 1–9, n = 12; d0/0 2–10, n = 22).
Although the amplitude of the hyperpolarizing current step signifi-
cantly influenced the mean number of spikes per rebound burst
(F3,162 = 104.80, P < 0.001, mixed ANOVA), there was no significant
effect of genotype on this relationship (F6,162 = 1.00, P = 0.43,
mixed ANOVA, Fig. 6D). Supra-threshold depolarizing current steps
of increasing amplitude generated tonic spikes of increasing fre-
quency in VB neurons derived from each mouse strain (Fig. 6A–C
and E). Although visual inspection of the resulting I-O curves
(Fig. 6E) suggests a modest left-ward trend of the relationship
towards increased excitability for d0/0 relative to WT recordings, this
did not reach statistical significance (F5,215 = 1.46, P = 0.20, mixed
ANOVA). Indeed, estimation of the current amplitude generating half
maximal spike output (EA50) from Boltzmann sigmoidal curve fits
(see Methods) indicated a small, but non-significant effect of d subunit
deletion on the I-O EA50 (WT = 173  7 pA, n = 23; a10/0 =
168  10 pA, n = 12; d0/0 = 158  8 pA, n = 22, F2,54 = 1.00,
P = 0.37, one way ANOVA). Similarly, neither the resting membrane
potential nor IR of VB neurons was significantly influenced by
deletion of the d subunit, although again a trend towards an increased
IR was observed relative to WT (IR, WT = 288  13 MΩ, n = 38;
d0/0 = 328  20 MΩ, n = 27, P = 0.1, unpaired t-test, Table 3).
In accordance with the large potentiation of tonic inhibition, bath
application of 3 lM etomidate hyperpolarized the resting Vm,
reduced membrane IR and exerted a clear reduction in the excitabil-
ity of WT VB neurons (Table 4, Fig. 7A–C). Thus, etomidate sig-
nificantly reduced the number of spikes per rebound burst upon
release from hyperpolarizing stimulations, although the effect was
particularly evident for smaller amplitude current steps (Fig. 7A and
B). Similarly, etomidate reduced the tonic spike output, resulting in a
clear rightward shift of the I-O relationship of VB neurons (Fig. 7A
and C). Indeed, the EA50 determined from Boltzmann fits to I-O
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Fig. 4. Etomidate delays the timing of post-inhibitory rebound burst firing
in VB neurons. (A, B) Exemplar traces from a subset of current-clamp
recordings obtained from WT (A) and d0/0 (B) mice in which rebound burst
firing was observed at the offset of eIPSPs. The responses to three consecu-
tive stimuli recorded before (black traces) and after (grey traces) application
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(n = 5) VB neurons. **P < 0.01, ***P < 0.001, paired t-test.
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curves was significantly increased in the presence of the anaesthetic
(EA50: control = 170  12 pA; + etomidate = 195  12 pA,
n = 12, P < 0.001). By contrast, although etomidate also hyperpolar-
ized the resting Vm and decreased the membrane IR of a1
0/0 VB neu-
rons (Table 4), the consequent reduction of their excitability was less
than for WT neurons (Fig. 7D–F). These findings are consistent with
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rent steps of increasing amplitude in VB neurons derived from WT, a10/0 and d0/0 mice. Symbols and n numbers are as indicated for D. The input–output rela-
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the reduced enhancement of tonic inhibition by the anaesthetic
following a1 subunit deletion. This was particularly evident upon
inspection of the I-O relationship generated from depolarizing stimula-
tions, where the rightward shift in the curve induced by etomidate
(EA50: control = 166  11 pA, + etomidate = 178  13 pA,
n = 11, P = 0.03) was significantly reduced relative to WT recordings
(Table 5). Deletion of the d subunit virtually abolished the effect of
etomidate on VB burst and tonic firing (Fig. 7G–I), consistent with
the limited etomidate-induced outward current observed in d0/0 volt-
age-clamp experiments. In addition, for d0/0 neurons, etomidate had
minimal effect on the resting Vm, or on the membrane input resistance
(Table 4). Thus, with the exception a small effect at the smallest cur-
rent step, which was significantly reduced relative to that observed in
WT recordings (P = 0.019 unpaired t-test), etomidate did not signifi-
cantly influence rebound intra-burst spike number in response to hy-
perpolarizing current steps (Fig. 7H). Similarly, for d0/0 neurons, the
I-O curve generated in response to positive current steps remained rel-
atively unaffected by etomidate (EC50: control = 163  14 pA,
+ 3 lM etomidate = 163  15 pA, n = 9, P = 0.95, Fig. 7I; Table 5).
Discussion
In this study, we investigated the relative contribution of synaptic
and extrasynaptic GABAARs to the etomidate-induced inhibition of
neuronal activity in a network putatively involved in general anaes-
thetic mechanisms. Specifically, deletion of the d subunit reduced
the effect of etomidate on VB tonic inhibition. Consequently, the
ability of etomidate to inhibit burst and tonic spiking was virtually
abolished in d0/0 mice, suggesting that etomidate facilitation of tonic
inhibition exerts a dominant effect on TC cell output. Unexpectedly,
deletion of the a1 subunit also reduced the impact of etomidate on
VB tonic inhibition and the relay neuron I-O relationship, thus
implicating the a1-GABAAR population during anaesthetic actions
in thalamus. Importantly, etomidate also greatly prolonged the dura-
tion of nRT burst-mediated phasic inhibition, by potentiating both
synaptic and extrasynaptic GABAARs. Thus, further to conventional
phasic and tonic inhibition, burst-mediated spill-over may represent
a novel mechanism whereby anaesthetics can modulate circuit func-
tion.
While anaesthetics probably exert their behavioural effects by
altering neuronal activity across multiple brain regions (Franks,
2008), human neuro-imaging studies have identified a consistent tha-
lamic deactivation during anaesthetic-induced sedation and/or loss
of consciousness (Fiset et al., 1999; Alkire et al., 2000; White &
Alkire, 2003; Hofbauer et al., 2004; Gili et al., 2013). Such studies
are consistent with the canonical view of the thalamus as a sensory
‘gate’ that governs the transmission of multi-modal information to
the cortex (Steriade, 2003). In vivo, anaesthetics may modulate tha-
lamic activity directly by influencing the intrinsic excitability of resi-
dent thalamic neurons or indirectly by altering the activity of
extrinsic excitatory inputs (e.g. descending cortico-thalamic, or
ascending reticular activating system inputs). Indeed, single-unit
recordings from cats showed a reduction of the spontaneous tonic
firing rate of TC neurons by etomidate, alongside similar decreases
in the neocortex and reticular formation (Andrada et al., 2012).
Computer simulations utilizing thalamocortical network models have
also provided important insights, revealing that elevated inhibition
of cortical and thalamic neurons imposes a slowed, hyper-synchro-
nous rhythmicity upon the thalamocortical loop that is reminiscent
of electroencephalography dynamics during anaesthetized states
(Talavera et al., 2009; Ching et al., 2010; Purdon et al., 2013). Col-
lectively, such studies favour a co-ordinated action of anaesthetics
across key interconnected networks, rather than a specific localized
effect. Nevertheless, our data support the hypothesis that etomidate
mediates at least a component of its actions by a direct reduction of
TC neuron output, resulting from enhanced synaptic and extrasynap-
tic GABAAR function. In agreement, propofol and the volatile agent
isoflurane also inhibit relay neuron tonic spiking in a manner that is
at least partially GABAAR-dependent (Ying & Goldstein, 2005a,b;
Jia et al., 2008).
That some general anaesthetics exert their spectrum of behaviour-
al effects via a selective interaction with the GABAAR is well estab-
lished (Hales & Lambert, 1991; Franks & Lieb, 1994). In support,
mutant mice harbouring point-mutated GABAARs engineered to be
etomidate-insensitive (b2N265S; Belelli et al., 1997; Reynolds
et al., 2003) or propofol- and etomidate-insensitive (b3N265M; Pis-
tis et al., 1999; Jurd et al., 2003) display dramatically altered
behavioural responses to these anaesthetics, revealing that specific
anaesthetic behaviours can be assigned to individual GABAAR pop-
ulations. Specifically, the sedative and immobilizing effects of both
etomidate and propofol are mediated by b2- and b3-containing
receptors, respectively, whereas both receptor populations contribute
to the hypnotic component (Jurd et al., 2003; Reynolds et al.,
2003). However, these studies did not address which b2- or b3-
expressing neuronal populations may be involved in the respective
behaviours. Thus, it is noteworthy that the effects of etomidate on
relay cell phasic and tonic currents are greatly reduced in b2N265S
slices (Belelli et al., 2005). In light of the present evidence for a
reduced etomidate-induced inhibition of relay neuron spiking in
a10/0 and d0/0 mice, such studies implicate synaptic (a1b2c2) and
extrasynaptic (a4b2d) GABAARs as important molecular targets for
the thalamic actions of this anaesthetic.
The effect of etomidate on VB tonic inhibition was virtually abol-
ished in d0/0 mice, leading to a reduced inhibitory effect on burst
and tonic spiking. Such observations are consistent with the tonic
conductance generating an inhibitory charge which greatly out-
weighs that produced by brief, spontaneous phasic inhibition. In
agreement, computational studies utilizing a thalamocortical network
model suggest that enhanced tonic inhibition is critical for the etom-
idate-induced depression of thalamic firing (Talavera et al., 2009).
Thus, the significant effect of the a1 subunit deletion (albeit lesser
than for the d0/0) was unexpected. One potential interpretation
Table 4. Comparison of the effect of etomidate on the resting membrane potential (Vm) and input resistance of WT, a1
0/0 and d0/0 VB neurons
WT (n = 19) a10/0 (n = 12) d0/0 (n = 11)
Control 3 lM etomidate Control 3 lM etomidate Control 3 lM etomidate
Vm (mV) –71.7  0.8 –73.2  0.9*** –71.7  0.8 –73.2  0.9*** –74.6  0.6 –75.5  0.7*
Input resistance 258  14 193  11*** 285  26 247  23** 287  31 275  27
*P < 0.05, **P < 0.01, ***P < 0.001, paired t-test.
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suggests that a subpopulation of d-GABAARs may contain the a1
subunit instead of a4. Indeed, a1 can form a functional partnership
with the d subunit in some hippocampal interneurons (Glykys et al.,
2007). However, while a1 subunit deletion abolishes spontaneous
phasic inhibition in VB (Peden et al., 2008), we did not detect a
significant reduction of baseline tonic inhibition, or the current
induced by the d-selective agonist THIP (4,5,6,7-tetrahydroisoxazolo
[5,4-c]pyridin-3-ol), which does not discriminate between a1bd and
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tative whole-cell current-clamp recording from a WT VB neuron, illustrating superimposed voltage responses to the indicated current steps (middle) under
control conditions (top) and in the presence of 3 lM etomidate (bottom). (B) Graph comparing the intra-burst spike number observed on rebound from a range
of hyperpolarizing current steps (200 to 50 pA), before (black symbols) and after (grey symbols) etomidate (n = 12). (C) Graph comparing the number of
spikes generated in response to depolarizing current steps of increasing amplitude (50–300 pA) under control conditions (black symbols), and in the presence
of etomidate (grey symbols). (D–F) Effect of etomidate on the excitability of a10/0 VB neurons (n = 11). Figure details are as described for A–C. (G–I) Effect
of etomidate on the excitability of d0/0 VB neurons (n = 9). Figure details are as described for A–C. The input–output relationships determined for each
condition are fitted with a Boltzmann curve. *P < 0.05, **P < 0.01, ***P < 0.001, paired t-test. Etom, etomidate.
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a4bd receptors (B. Ebert, personal communication; Herd et al.,
2009), suggesting that a1bd receptors are not abundantly expressed
in VB neurons. Alternatively, the loss of on-going spontaneous pha-
sic inhibition, which is robustly prolonged by etomidate in WT neu-
rons, may partially account for the reduced effect of the anaesthetic
on spike discharge for a10/0 relay neurons. Additionally, a substan-
tial pool of a1bc2 receptors may exist extrasynaptically (Kasugai
et al., 2010). While this receptor population does not appear to con-
tribute to baseline tonic inhibition, etomidate, which increases
GABAAR channel open probability in response to low GABA con-
centrations (Yang & Uchida, 1996), may enhance the activation of
extrasynaptic a1b2c2 receptors by ambient GABA. Finally, we can-
not exclude that direct activation of a1b2c2 receptors by etomidate
(Hill-Venning et al., 1997) may influence VB neuron excitability.
Using paired nRT–VB recordings, we recently reported that peri/
extrasynaptic a4bd receptors are recruited during nRT burst firing,
leading to a substantial prolongation of burst-mediated phasic inhibi-
tion (Herd et al., 2013). In support of this, despite the absence of
synaptic GABAARs, we observed a residual eIPSC in a1
0/0 VB neu-
rons, which was greatly potentiated by the d-selective positive allo-
steric modulator DS2 (Herd et al., 2013). Here, we observed a
similar potentiation of the residual eIPSC upon application of etomi-
date to a10/0 slices. Consequently, the remarkable ability of the
residual eIPSPs to suppress tonic spiking of a10/0 neurons was
greatly prolonged by etomidate. In a40/0 and d0/0 mice, eIPSCs are
shorter due to the abolished spill-over component, and are insensi-
tive to DS2, consistent with the loss of a4bd receptors (Herd et al.,
2013). In contrast to DS2, in d0/0 recordings, etomidate significantly
prolonged eIPSCs and therefore the eIPSP-induced suppression of
tonic spiking. Curiously, for the latter paradigm, the duration of
spike suppression induced by the eIPSP in the presence of etomidate
was not significantly different from WT in either a10/0 or d0/0 neu-
rons (Fig. 3D), despite a clear effect of both gene deletions under
control conditions (Fig. 2D). In current-clamp recordings the dura-
tion of IPSPs is determined partially by the kinetic properties of
GABAARs, but also by the ensuing activation of voltage-dependent
conductances (e.g. IH and IT), which may act to truncate the IPSP
time course (Thomson et al., 2000). Thus, we speculate that the
duration of the IPSP may be maximized in the presence of the
anaesthetic and that this ‘ceiling effect’ may be achieved via
the potentiation of either synaptic or extrasynaptic GABAARs in the
absence of the complementary receptor population. Nevertheless, the
results suggest that etomidate facilitates burst-mediated inhibition
via a combined action at synaptic and peri/extrasynaptic GABAARs,
leading to an amplified inhibitory effect on VB tonic firing.
As noted above, the strength of synaptic inhibition arising from
nRT neurons interacts with intrinsic voltage-dependent conductances
to control the timing of post-inhibitory rebound bursts, and thus the
period and synchrony of thalamus-dependent oscillations, which pre-
vail in the unconscious brain (Huguenard & McCormick, 2007). In
addition to an enhanced tonic inhibition, which induces a membrane
hyperpolarization that is likely to favour burst firing (Cope et al.,
2005), etomidate also delayed the timing of post-inhibitory rebound
burst firing by prolonging the IPSP. Given the importance of burst
firing during thalamocortical rhythmogenesis, the etomidate-induced
increase of IPSP duration may therefore contribute to the slowed
oscillatory activity of the anaesthetized brain.
Our in vitro data, together with a computational study (Talavera
et al., 2009), suggest that the etomidate-induced inhibition of TC
output is dependent on synaptic and extrasynaptic GABAARs. Thus,
it is surprising that deletion of a1, a4 or d subunits exerts little
or no influence on the sedative or hypnotic actions of etomidate
(Mihalek et al., 1999; Kralic et al., 2003; Iyer et al., 2013). How-
ever, the interpretation of behavioural data obtained from mice
harbouring global GABAAR subunit deletions is complicated by the
non-uniform up-regulation of alternative GABAAR isoforms follow-
ing subunit loss (Sur et al., 2001; Kralic et al., 2002a,b; Peng et al.,
2002). This caveat is exemplified by studies investigating the sub-
unit-dependence of benzodiazepine-induced behaviours; mice
expressing a benzodiazepine-insensitive a1 subunit (H101R) are
resistant to the sedative effects of diazepam (Rudolph et al., 1999;
McKernan et al., 2000), yet a10/0 mice exhibit enhanced diazepam-
induced sedation (Kralic et al., 2002b). Thus, caution is warranted
when comparing results from a slice preparation demonstrating mini-
mal functional GABAAR compensation to behavioural studies
underpinned by complex interactions between multiple brain net-
works subject to varying degrees of compensation. We note that an
as yet unidentified neuronal adaptation (e.g. as described by
Brickley et al., 2001) is likely to compensate for the loss of tonic or
phasic inhibition in relay neurons, as demonstrated by the lack of
any significant alteration in membrane IR or the I-O relationship in
the mutant mice. Crucially, however, such adaptations do not appear
to include upregulation of the remaining palette of GABAAR subun-
its (Kralic et al., 2006; Peden et al., 2008; Herd et al., 2009).
In summary, we have shown that etomidate reduces the electrical
excitability of thalamocortical relay neurons via a specific interaction
with synaptic and extrasynaptic GABAARs. Given the established
role of the thalamus in arbitrating conscious state transitions, our
results support the putative role of these distinct thalamic GABAAR
populations in general anaesthetic actions. Finally, we suggest that
burst-mediated spill-over, a kinetically intermediate form of inhibi-
tion that bridges the kinetic extremes of fast phasic and slow tonic
inhibition, represents a novel means by which GABA-modulatory
anaesthetics may influence the relay of sensory information from
thalamus to cortex.
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acid, type A receptor; eIPSC, evoked IPSC; eIPSP, evoked IPSP; Erev, reversal
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Table 5. Comparison of the effect of etomidate on the input–output rela-
tionship of WT, a10/0 and d0/0 VB neurons
Etomidate-induced change in EA50 (pA)
WT (n = 12) 25  4
a10/0 (n = 11) 12  5*
d0/0 (n = 19) 0  6**
*P < 0.05, **P < 0.01, vs. WT, one-way ANOVA, Tukey’s post-hoc test.
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current; IPSP, inhibitory postsynaptic potential; IR, membrane input resistance;
ISI, inter-spike interval; IT, current mediated by low threshold T-type Ca
2+
channels; mIPSC, miniature IPSC; nRT, nucleus reticularis thalami; TC,
thalamocortical; VB, ventrobasal complex; Vm, membrane potential; WT, wild-
type; a10/0, a1 subunit knock-out mouse; a1-GABAAR, a1 subunit-
containing GABAA receptor; b3N265M, asparagine to methionine
mutation at position 265 of the GABAA receptor b3 subunit; b2N265S,
asparagine to serine mutation at position 265 of the GABAA receptor b2
subunit; d0/0, d subunit knock-out mouse; d-GABAAR, d subunit-
containing GABAA receptor; sw, weighted decay time constant.
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